EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/17/2025
Back to search
Official data from USPTO
D DEMENTIA DISCOVERY FUND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/21/2025
Trademark type
Combined
Nice classes
5, 36, 42, 44
Filing date
09/09/2019
Registration date
04/19/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/19/2022
Last transaction
03/21/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
21
Owner location
GB
Examiner
DIBLE, JONATHON I
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the dark blue stylized wording "DEMENTIA" above the light blue stylized wording "DISCOVERY" above the green stylized wording "FUND", all to the right of a stylized letter "D" represented by multiple shaded dots colored in various shades of green, light blue, dark blue, and purple and connected by gray lines arranged to form triangular outlines. The color white appearing in the mark represents background and is not claimed as a feature of the mark.
Holders and representatives
Holders
S. L. (pessoa física)
Representatives
Syed Abedi Seed IP Law Group LLP
Technical classification
Nice Classes
Class 5Class 36Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations and substances for the treatment of dementia; Pharmaceutical and medical preparations and substances for use in the treatment and prevention of dementia; Sanitary preparations for medical purposes; Pharmaceutical preparationsall for use in the treatment and prevention of brain diseases and degenerative dementia disorders; Antiseptic preparations; Prescription pharmaceuticals for humans as well as other pharmaceutical products for the treatment of dementia; Dietetic foods adapted for medical usedietary and health food supplements; Vitamins; Dietetic substances adapted for medical usefood for babiesteensadultselders; Homeopathic preparations and substances for the treatment of dementia; Medicated drinks; Anti-diabetic drugs; Hypertension medications; Steroid hormones; Non-steroidal anti-inflammatory drugs
Class 36
Insurance agency and brokerage; Financial affairs and monetary affairsfinancial informationmanagementanalysis services; Real estate agency services; Financial servicesfinancing the medical research of others; Arranging of financing for humanitarian aid and developmentincluding charitable fundraising and support services for research in dementia; Charitable fundraising regarding funding for dementia research; Charitable servicesproviding financial assistance to disadvantaged persons for foodclothinghealth care; Financial sponsorship services of charitable musical entertainmentrunning and walkingfood tastingdinner and dance events; Financial servicesmanaging and monitoring of charitable funds supporting dementia research; Accepting and administering monetary charitable contributionsdistribution and allocation of charitable funds; Providing of information in the field of charitable monetary giving through corporate donations and payroll donations by employees; Informationadvisoryconsultancy services in relation to the aforesaid services
Class 42
Scientific and technological servicesresearch and design in the field of goods and services connected with dementia treatment; Scientific and technological servicesresearch and design in the field of goods and services connected with dementia; Industrial analysis and research services in the field of goods and services connected with dementia treatment to assure compliance with industry standards; Design and development of computer hardware and software; Design and development of computer hardware and software connected with dementia; Laboratory analysis in the field of goods and services connected with dementia treatment; Laboratory research in the field of goods and services connected with dementia treatment; Laboratory research services in the field of goods and services connected with dementia treatment; Scientific and technological serviceslaboratory testing services in the field of goods and services connected with dementia treatment; Medical laboratory services; Medical and scientific research services in relation to the causessymptomsdiagnosistreatment and prevention of dementia; Genetic research concerning dementia; Provision of medical and scientific research facilities; Medical and scientific research laboratories; Medical and scientific research in relation to medicines and pharmaceuticals; Medical research services; Design and development of software in the field of mobile device applications; Design and development of computer programmes
Class 44
Medical services; The provision of informationonline via the Interneton the subject of all aspects of dementia diseases and the prevention of all types dementia diseases; Medical services relating to the science of nutrition and the use of medical and pharmaceutical preparations and substances; Medical services in relation to the recommendation and prescribing of medicaments and medical products of all kinds; Medical services concerning dementiaphysiciannursingmidwiferyhospital services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Hygienic and beauty care for human beings; Agricultural advice services; Dentistry services; Medical analysis for the diagnosis and treatment of individuals and groups of people with dementia related to x-ray examinations and taking blood samples; Pharmaceutical advice; Medical clinic services; Medical treatment services; Medical analysis services; Nursing services; Informationadvisoryconsultancy services relating to all the aforesaid
Publications
History of USPTO decisions and trademark events.
38 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/17/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/17/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/17/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/22/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/01/2022
FIMP
FINAL DISPOSITION PROCESSED
09/01/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2022
PUBO
PUBLISHED FOR OPPOSITION
02/01/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/29/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/12/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/12/2022
ALIE
ASSIGNED TO LIE
12/29/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/22/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/03/2021
GNFR
FINAL REFUSAL E-MAILED
12/03/2021
CNFR
FINAL REFUSAL WRITTEN
12/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/26/2021
RFNT
REFUSAL PROCESSED BY IB
05/31/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/03/2021
RFRR
REFUSAL PROCESSED BY MPU
05/03/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/29/2021
CNRT
NON-FINAL ACTION WRITTEN
04/28/2021
MAFR
APPLICATION FILING RECEIPT MAILED
04/20/2021
DOCK
ASSIGNED TO EXAMINER
04/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/15/2021
Continuous trademark protection
Get notified about every new filing that threatens D DEMENTIA DISCOVERY FUND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.